Michael Anstey

Chief Investment Officer at

Congenica Ltd.

45 year

96 connections

Health Technology

Finance

Consumer Services

Profile

Michael Anstey is the founder of Proteorex Therapeutics, Inc., founded in 2014.
Current jobs include Director at Buckman Laboratories SARL, Director & Investment Director at Congenica Ltd. since 2019, Director at Start Codon Ltd. since 2019, Director at Epitopea Ltd. since 2021, and Partner at Cambridge Innovation Capital Ltd since 2017.
Former jobs include Independent Director at Bicycle Therapeutics Plc from 2017 to 2020, Director at STORM Therapeutics Ltd., Director at Sense Biodetection Ltd. from 2019 to 2023, Principal-Healthcare Practice Area at The Boston Consulting Group, Inc. from 2010 to 2017, Investment Analyst at Oxford Capital Partners LLP from 2008 to 2009, and Board Member at Polyprox Therapeutics Ltd. Education includes a doctorate from the University of Oxford conferred in 2007 and an undergraduate degree from Queen's University conferred in 2003.

Michael Anstey active positions

Companies	Position	Start
Buckman Laboratories SARL Buckman Laboratories SARL Chemicals: Major DiversifiedProcess Industries Whole sells chemicals	Director/Board Member	2010-02-07
Cambridge Innovation Capital Ltd Cambridge Innovation Capital Ltd Investment ManagersFinance Cambridge Innovation Capital seeks investment opportunities in companies located in the United Kingdom. The firm focuses on technology and life science companies. It participates in seed, early and late stage capital transactions. The firm makes co-investments.	Private Equity Investor	2016-12-31
Congenica Ltd. Congenica Ltd. Packaged SoftwareTechnology Services Operates as a digital health company that enables analysis of genomic data	Chief Investment Officer	2018-12-31
Start Codon Ltd. Start Codon Ltd. Investment ManagersFinance Start Condon invest in private companies located in the United Kingdom. The firm focuses on the healthcare sector. It participates in seed, early and later stage capital requirements with an investment size of GBP 250,000.	Director/Board Member	2019-03-31
Epitopea Ltd. Epitopea Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on biotechnology	Director/Board Member	2021-10-31

All active positions of Michael Anstey

Former positions of Michael Anstey

Companies	Position	End
Sense Biodetection Ltd. Sense Biodetection Ltd. Medical/Nursing ServicesHealth Services Engages in molecular diagnostic testing	Director/Board Member	2022-12-31
BICYCLE THERAPEUTICS PLC	Director/Board Member	2020-06-29
Proteorex Therapeutics, Inc. Proteorex Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapeutics	Founder	2018-11-30
The Boston Consulting Group, Inc. The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services	Corporate Officer/Principal	2016-12-31
░░░░░░ ░░░░░░░ ░░░░░░░░ ░░░	░░░░░░░ ░░░░░░ ░░░░░░░	░░░░░░░░░░

See the detail of Michael Anstey's experience

Training of Michael Anstey

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Michael Anstey's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	14
University of Oxford University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
The Boston Consulting Group, Inc. The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services	Commercial Services
Queen's University Queen's University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Oxford Capital Partners LLP Oxford Capital Partners LLP Investment ManagersFinance Oxford Capital Partners invests in companies located in the United Kingdom. The firm focuses on a broad range of sectors and industries. It provides financing for seed and early stage capital transactions. The firm makes co-investments and takes a seat on the board of directors. The firm makes follow-on investments.	Finance
Bicycle Therapeutics Plc Bicycle Therapeutics Plc Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops molecules and oncology medicines	Health Technology
Buckman Laboratories SARL Buckman Laboratories SARL Chemicals: Major DiversifiedProcess Industries Whole sells chemicals	Process Industries
Congenica Ltd. Congenica Ltd. Packaged SoftwareTechnology Services Operates as a digital health company that enables analysis of genomic data	Technology Services
Cambridge Innovation Capital Ltd Cambridge Innovation Capital Ltd Investment ManagersFinance Cambridge Innovation Capital seeks investment opportunities in companies located in the United Kingdom. The firm focuses on technology and life science companies. It participates in seed, early and late stage capital transactions. The firm makes co-investments.	Finance
STORM Therapeutics Ltd. STORM Therapeutics Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops molecule drugs through RNA biology for the treatment of cancer, inflammation, viruses and CNS diseases	Health Technology
Sense Biodetection Ltd. Sense Biodetection Ltd. Medical/Nursing ServicesHealth Services Engages in molecular diagnostic testing	Health Services
Proteorex Therapeutics, Inc. Proteorex Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapeutics	Health Technology
Start Codon Ltd. Start Codon Ltd. Investment ManagersFinance Start Condon invest in private companies located in the United Kingdom. The firm focuses on the healthcare sector. It participates in seed, early and later stage capital requirements with an investment size of GBP 250,000.	Finance
Polyprox Therapeutics Ltd. Polyprox Therapeutics Ltd. BiotechnologyHealth Technology Operates as biotechnology company which engages in research and development of drugs to treat cancer and neurodegenerative diseases	Health Technology
Epitopea Ltd. Epitopea Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on biotechnology	Commercial Services